HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Open in Screener

CARS

Cars.com

Last Close
Oct 31 • 04:00PM ET
15.99
Dollar change
-0.01
Percentage change
-0.06 		%
Peers: AN KMX CVNA GPI LAD PAG ABG SAH VRM MPAA
 | Held by: IJR CALF VTI IWM VB VBR AVUV VXF IWN IJT
IndexRUT P/E43.55 EPS (ttm)0.37 Insider Own8.59% Shs Outstand65.93M Perf Week1.40%
Market Cap1.06B Forward P/E6.98 EPS next Y2.29 Insider Trans-2.04% Shs Float60.35M Perf Month-0.74%
Income25.00M PEG2.22 EPS next Q0.45 Inst Own89.41% Short Float3.03% Perf Quarter-17.24%
Sales713.01M P/S1.48 EPS this Y-53.59% Inst Trans0.31% Short Ratio3.18 Perf Half Y-5.38%
Book/sh7.51 P/B2.13 EPS next Y27.07% ROA2.27% Short Interest1.83M Perf Year4.99%
Cash/sh0.44 P/C36.31 EPS next 5Y19.60% ROE5.13% 52W Range14.82 - 21.24 Perf YTD-15.71%
Dividend Est.- P/FCF7.25 EPS past 5Y25.84% ROI2.59% 52W High-24.72% Beta2.10
Dividend TTM- Quick Ratio1.53 Sales past 5Y1.21% Gross Margin52.82% 52W Low7.89% ATR (14)0.42
Dividend Ex-DateNov 03, 2005 Current Ratio1.53 EPS Y/Y TTM-77.82% Oper. Margin7.42% RSI (14)46.95 Volatility2.35% 2.64%
Employees1700 Debt/Eq0.95 Sales Y/Y TTM6.73% Profit Margin3.51% Recom2.14 Target Price21.21
Option/ShortYes / Yes LT Debt/Eq0.95 EPS Q/Q-87.79% Payout0.00% Rel Volume0.74 Prev Close16.00
Sales Surprise-1.62% EPS Surprise-15.14% Sales Q/Q6.37% EarningsNov 07 BMO Avg Volume574.30K Price15.99
SMA201.27% SMA50-4.52% SMA200-10.59% Trades Volume427,398 Change-0.06%
Date Action Analyst Rating Change Price Target Change
Aug-09-24Downgrade JP Morgan Overweight → Neutral $25 → $19
Sep-15-23Initiated UBS Neutral $20
Jul-20-23Initiated B. Riley Securities Buy $26
Jun-27-23Initiated JP Morgan Overweight $23
Jun-21-22Reiterated BTIG Research Buy $19 → $16
Feb-02-22Initiated Northcoast Neutral
Aug-27-21Initiated Truist Buy $18
Mar-01-21Upgrade The Benchmark Company Hold → Buy $18
Oct-15-20Upgrade Craig Hallum Hold → Buy $14
Oct-15-20Upgrade B. Riley Securities Neutral → Buy $9 → $11
Show Previous Ratings
Today 10:01AM
Cars.com (CARS) Reports Next Week: Wall Street Expects Earnings Growth
(Zacks)
Oct-24-24 07:30AM
CARS to Announce Third Quarter 2024 Financial Results
(PR Newswire)
Oct-21-24 07:30AM
Surplus Inventory Slightly Drives Down New-Car Prices as Used-Car Market Stabilizes, According to Cars Commerce's September Industry Insights Report
(PR Newswire)
Oct-09-24 05:43PM
Cars.com Inc (CARS) Q2 2024 Earnings Call Highlights: Revenue Growth and Strategic OEM ...
(GuruFocus.com)
03:57AM
Reflecting On Online Marketplace Stocks Q2 Earnings: Cars.com (NYSE:CARS)
(StockStory)
01:14PM Loading…
Oct-08-24 01:14PM
Cars.com Inc. (CARS): Street Analysts Are Bullish On This Undervalued Auto Stock Now
(Insider Monkey)
Sep-20-24 04:47AM
Q2 Earnings Highs And Lows: Teladoc (NYSE:TDOC) Vs The Rest Of The Online Marketplace Stocks
(StockStory)
Sep-19-24 07:30AM
Cars Commerce's Industry Insights Report Shows a Stabilizing Market; Ford, Chevrolet and Honda Drive Balanced New-Car Inventory Levels in August
(PR Newswire)
Sep-03-24 08:30AM
Is the Options Market Predicting a Spike in Cars.com (CARS) Stock?
(Zacks)
Aug-30-24 03:13AM
Unpacking Q2 Earnings: CarGurus (NASDAQ:CARG) In The Context Of Other Online Marketplace Stocks
(StockStory)
Aug-26-24 04:18AM
Winners And Losers Of Q2: Robinhood (NASDAQ:HOOD) Vs The Rest Of The Online Marketplace Stocks
(StockStory)
Aug-22-24 08:15AM
Bear of the Day: Cars.com (CARS)
(Zacks)
04:02AM
Q2 Rundown: MercadoLibre (NASDAQ:MELI) Vs Other Online Marketplace Stocks
(StockStory)
Aug-19-24 04:20AM
Reflecting On Online Marketplace Stocks Q2 Earnings: Coinbase (NASDAQ:COIN)
(StockStory)
Aug-16-24 07:30AM
New-Car Market Sees Sharp Decline in Sub-$30,000 Vehicles, According to Cars Commerce Industry Insights Report
(PR Newswire)
07:30AM Loading…
Aug-13-24 07:30AM
Family First: Cars.com Survey Finds Over 60% of Parents Purchase a Vehicle Based on Car Seat Needs
(PR Newswire)
Aug-09-24 09:40AM
Should Value Investors Buy Cars.com (CARS) Stock?
(Zacks)
02:21AM
Q2 2024 Cars.com Inc Earnings Call
(Thomson Reuters StreetEvents)
Aug-08-24 09:30AM
Cars.com (CARS) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
(Zacks) -5.99%
08:45AM
Cars.com (CARS) Lags Q2 Earnings and Revenue Estimates
(Zacks)
08:37AM
Cars.com (NYSE:CARS) Reports Sales Below Analyst Estimates In Q2 Earnings, Stock Drops 10.6%
(StockStory)
07:30AM
Cars.com Reports Second Quarter 2024 Results
(PR Newswire)
Aug-07-24 03:10AM
Earnings To Watch: Cars.com (CARS) Reports Q2 Results Tomorrow
(StockStory)
Aug-06-24 09:15AM
Impel Strengthens C-Suite, Adding Veteran Auto Tech Execs as CTO and CPO, and Creating 3 New Executive Positions Amid Aggressive Global Expansion
(PR Newswire)
Aug-05-24 12:30AM
Why Are Hedge Funds Bullish on Cars.com, Inc. (CARS) Now?
(Insider Monkey) -6.06%
Jul-26-24 07:30AM
Auto Industry Sees Significant Shifts in First Half of 2024; Nearly Unrecognizable From Five Years Ago, According to Cars Commerce Industry Insights Report
(PR Newswire)
Jul-25-24 10:02AM
Earnings Preview: Cars.com (CARS) Q2 Earnings Expected to Decline
(Zacks)
07:30AM
Cars.com to Announce Second Quarter 2024 Financial Results
(PR Newswire)
Jul-23-24 09:40AM
Are Investors Undervaluing Cars.com (CARS) Right Now?
(Zacks)
Jul-22-24 07:00AM
Small Caps, Big Returns: 3 Dynamic Russell 2000 Stocks to Buy in July
(InvestorPlace)
03:39AM Loading…
Jul-15-24 03:39AM
Reflecting On Online Marketplace Stocks Q1 Earnings: ACV Auctions (NASDAQ:ACVA)
(StockStory)
Jul-09-24 01:30PM
The 3 Most Undervalued Under-$50 Stocks to Buy in July 2024
(InvestorPlace)
Jun-28-24 12:00PM
All You Need to Know About Cars.com (CARS) Rating Upgrade to Buy
(Zacks)
07:30AM
Foreign Automakers Lead the Charge in Cars.com's American-Made Index
(PR Newswire)
04:43AM
Q1 Earnings Outperformers: Cars.com (NYSE:CARS) And The Rest Of The Online Marketplace Stocks
(StockStory)
Jun-27-24 06:00AM
3 Used Car Stocks to Buy as More Consumers Skip Buying New
(InvestorPlace)
Jun-18-24 11:47AM
Tesla's Model Y leads American-Made Index, followed by foreign automakers
(Quartz)
07:45AM
Incumbent Tesla is the Only Domestic Automaker in Cars.com's 2024 American-Made Index Top 10
(PR Newswire)
Jun-13-24 07:30AM
May New-Car Sales Boost Used-Car Inventory, Dropping Used-Car Prices 7% to $28,861, According to Cars Commerce May Industry Insights Report
(PR Newswire)
Jun-11-24 07:30AM
Cars Commerce Named in U.S. News & World Report's 2024-2025 Best Companies to Work For
(PR Newswire)
Jun-10-24 09:40AM
Should Value Investors Buy Cars.com (CARS) Stock?
(Zacks)
Jun-07-24 07:01PM
Insider Sale: Director Bryan Wiener Sells 10,000 Shares of Cars.com Inc (CARS)
(GuruFocus.com)
May-31-24 02:45AM
Insider Sale: CEO Thomas Vetter Sells 25,373 Shares of Cars.com Inc (CARS)
(GuruFocus.com)
May-24-24 12:00PM
Cars.com (CARS) Upgraded to Buy: What Does It Mean for the Stock?
(Zacks)
09:55AM
Does Cars.com (CARS) Have the Potential to Rally 32.07% as Wall Street Analysts Expect?
(Zacks)
09:40AM
Are Investors Undervaluing Cars.com (CARS) Right Now?
(Zacks)
May-16-24 07:30AM
Cars Commerce April Industry Insights Report Reveals New-Car Inventory Up 35% YoY but Remains a Million Units Below 2019 Levels With Prices Up 30% in the Same Time Frame
(PR Newswire)
May-13-24 07:02PM
Insider Selling: CEO Thomas Vetter Sells 27,625 Shares of Cars.com Inc (CARS)
(GuruFocus.com)
May-10-24 01:53PM
Cars.com Inc (CARS) Q1 2024 Earnings: Modest Profit Amid Revenue Growth
(GuruFocus.com) -5.58%
11:41AM
Cars.com Inc. (NYSE:CARS) Q1 2024 Earnings Call Transcript
(Insider Monkey)
May-09-24 09:30AM
Cars.com (CARS) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
(Zacks) +9.20%
07:35AM
Cars.com (NYSE:CARS) Reports Q1 In Line With Expectations
(StockStory)
07:35AM
Cars.com: Q1 Earnings Snapshot
(Associated Press Finance)
07:30AM
Cars.com Reports First Quarter 2024 Results
(PR Newswire)
May-08-24 03:05AM
Cars.com (CARS) Q1 Earnings: What To Expect
(StockStory)
Apr-28-24 09:04AM
5 Best Used Car Websites in USA
(Insider Monkey)
Apr-25-24 07:30AM
Cars.com to Announce First Quarter 2024 Financial Results
(PR Newswire)
Apr-16-24 07:30AM
Market Prices, Consumer Budgets Inch Closer Together, According to Cars.com's 2024 Affordability Report
(PR Newswire)
Apr-11-24 07:30AM
Tax Season Turbocharges Car Market: Dealers and Buyers Gear Up for a Surge in Shopping Activity, According to Cars Commerce March Industry Insights Report
(PR Newswire)
Apr-03-24 05:48AM
Q4 Rundown: Cars.com (NYSE:CARS) Vs Other Online Marketplace Stocks
(StockStory)
Apr-02-24 07:30AM
Cars.com's Your Garage Gives Car Owners Market Power for Trade-Ins and New Purchases, Showcased in Latest 'Possibilities' Ad
(PR Newswire)
Mar-12-24 12:12AM
Insider Sell: Cars.com Inc (CARS) Pres. and Chief Comm. Officer Douglas Miller Sells 16,167 Shares
(GuruFocus.com)
Mar-06-24 07:30AM
The Reviews Are In: Cars.com 2024 Dealer of the Year Awards Recognize the Best Local Car-Shopping Experiences Across America
(PR Newswire)
Feb-28-24 11:27PM
Insider Sell: Cars.com Inc (CARS) President and Chief Communications Officer Douglas Miller ...
(GuruFocus.com)
Feb-26-24 08:43AM
New Cars Are Finally Becoming More Affordable
(Barrons.com)
08:43AM
Car Prices Are Finally Coming Down. It Looks Like a Buyers Market.
(Barrons.com)
01:00AM
New Cars Are Becoming More Affordable. Thats Good for Buyers and Auto Stocks.
(Barrons.com)
Feb-24-24 08:30AM
Top reasons why 2024 is the year to buy an EV or new car
(Yahoo Finance Video)
Feb-23-24 12:07PM
Cars.com Inc. (NYSE:CARS) Q4 2023 Earnings Call Transcript
(Insider Monkey)
12:19AM
Q4 2023 Cars.com Inc Earnings Call
(Thomson Reuters StreetEvents)
Feb-22-24 09:30AM
Compared to Estimates, Cars.com (CARS) Q4 Earnings: A Look at Key Metrics
(Zacks)
08:40AM
Cars.com (CARS) Lags Q4 Earnings Estimates
(Zacks)
08:12AM
Cars.com Inc (CARS) Reports Robust Revenue Growth and Record Traffic in 2023
(GuruFocus.com)
07:47AM
Cars.com: Q4 Earnings Snapshot
(Associated Press Finance)
07:43AM
Cars.com (NYSE:CARS) Reports Q4 In Line With Expectations
(StockStory)
07:30AM
Cars.com Reports Fourth Quarter and Full Year 2023 Results
(PR Newswire)
Feb-21-24 02:01AM
Cars.com (CARS) Q4 Earnings Report Preview: What To Look For
(StockStory)
Feb-19-24 09:15AM
Ahead of Cars.com (CARS) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics
(Zacks)
Feb-16-24 11:42PM
Cars.com Inc CEO Thomas Vetter Sells 17,666 Shares
(GuruFocus.com)
Feb-12-24 04:30PM
Cars.com to Announce Fourth Quarter and Full Year 2023 Financial Results
(PR Newswire)
02:06PM
Volkswagen's 'An American Love Story' Ad Zooms Ahead With 394% Surge in Traffic on Cars.com During the Big Game
(PR Newswire)
Feb-07-24 07:30AM
Cars.com Reveals 2024 Best Of Awards: Budget-Friendly Chevrolet Trax Takes Top Spot as Best Car of the Year
(PR Newswire)
Jan-30-24 07:30AM
Cars Commerce Addresses Automotive Retailers' Top Three Pain Points to Help Them Unleash Growth in 2024
(PR Newswire)
Jan-24-24 07:30AM
FordDirect Selects AccuTrade as its Preferred Vehicle Acquisition and Trade and Appraisal Solution For Its 3000+ U.S. Ford Dealers and Lincoln Retailers to Turn More Cars for More Profit
(PR Newswire)
Jan-15-24 01:37AM
Q3 Earnings Highlights: Cars.com (NYSE:CARS) Vs The Rest Of The Online Marketplace Stocks
(StockStory)
Jan-03-24 07:30AM
2024 Automotive Trends: Cars Commerce Explores Driving Forces Transforming Car Buying and Selling
(PR Newswire)
Dec-02-23 01:04AM
Insider Sell Alert: CFO Sonia Jain Sells 22,328 Shares of Cars.com Inc
(GuruFocus.com)
Nov-30-23 01:04PM
Insider Sell Alert: CFO Sonia Jain Sells 39,191 Shares of Cars.com Inc
(GuruFocus.com)
07:30AM
13 Million Reviews Don't Lie: Cars.com Reveals Top Automakers With the Best Reputation
(PR Newswire)
Nov-16-23 05:13PM
CarMax, Carvana Shares Tumble After Amazon Says It Will Sell Cars
(Investopedia)
Nov-15-23 11:03PM
Insider Sell: CEO Thomas Vetter Sells 38,932 Shares of Cars.com Inc
(GuruFocus.com)
Nov-09-23 07:00AM
Cars.com to Participate in Three Investor Conferences in November
(PR Newswire)
Nov-04-23 12:48PM
Cars.com Inc. (NYSE:CARS) Q3 2023 Earnings Call Transcript
(Insider Monkey)
Nov-03-23 02:03AM
Q3 2023 Cars.com Inc Earnings Call
(Thomson Reuters StreetEvents) +7.79%
Nov-02-23 10:30AM
Compared to Estimates, Cars.com (CARS) Q3 Earnings: A Look at Key Metrics
(Zacks) +11.69%
09:15AM
Cars.com Inc (CARS) Reports 6% Revenue Growth and $4.5 Million Net Income in Q3 2023
(GuruFocus.com)
08:10AM
Cars.com: Q3 Earnings Snapshot
(Associated Press Finance)
07:33AM
Cars.com's (NYSE:CARS) Q3 Earnings Results: Revenue In Line With Expectations But Usage Drops
(StockStory)
07:30AM
Cars.com Inc. Reports Third Quarter 2023 Results
(PR Newswire)
07:15AM
Cars.com Inc. Acquires D2C Media Inc., Expanding Cars Commerce Platform into Canada in Accretive Transaction
(PR Newswire)
Cars.com, Inc. engages in the provision of an automotive marketplace platform and digital solutions that connect car shoppers with sellers. Its portfolio of brands includes Dealer Inspire, FUEL, DealerRater, CreditIQ, and NewCars.com. The company was founded by Mitch Golub, William Swislow, and T. Alex Vetter in 1998 and is headquartered in Chicago, IL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Vetter Thomas AlexCEOJul 12 '24Sale19.2317,674339,871598,934Jul 16 05:06 PM
Vetter Thomas AlexCEOJun 14 '24Sale20.0917,666354,910616,608Jun 18 05:20 PM
WIENER BRYANDirectorJun 05 '24Sale20.5110,000205,10062,913Jun 07 05:09 PM
Vetter Thomas AlexCEOMay 28 '24Sale19.0025,373482,087634,274May 30 05:51 PM
Marks Angelique StrongChief Legal OfficerMay 24 '24Sale18.5716,989315,486101,928May 28 05:57 PM
Marks Angelique StrongChief Legal OfficerMay 23 '24Sale18.502,84652,651118,917May 28 05:57 PM
Vetter Thomas AlexCEOMay 09 '24Sale19.0027,625524,875659,647May 13 04:55 PM
Miller Douglas NealPres. and Chief Comm. OfficerMar 08 '24Sale18.5414,344265,938167,252Mar 11 05:16 PM
Miller Douglas NealPres. and Chief Comm. OfficerMar 07 '24Sale18.501,82333,726181,596Mar 11 05:16 PM
Miller Douglas NealPres. and Chief Comm. OfficerMar 06 '24Sale18.1516,167293,431183,419Mar 07 04:20 PM
Vetter Thomas AlexCEOFeb 14 '24Sale19.0014,999284,981553,886Feb 16 05:02 PM
Vetter Thomas AlexCEOFeb 15 '24Sale19.002,66750,673551,219Feb 16 05:02 PM
Vetter Thomas AlexCEOFeb 12 '24Sale19.0017,666335,654568,885Feb 14 04:31 PM
Vetter Thomas AlexCEODec 14 '23Sale19.0017,666335,654586,551Dec 18 05:40 PM
Jain SoniaChief Financial OfficerNov 30 '23Sale18.6413,889258,891233,470Dec 01 04:19 PM
Jain SoniaChief Financial OfficerNov 29 '23Sale18.908,439159,497247,359Dec 01 04:19 PM
Jain SoniaChief Financial OfficerNov 27 '23Sale19.0221,956417,603273,033Nov 29 04:44 PM
Jain SoniaChief Financial OfficerNov 28 '23Sale18.9217,235326,086255,798Nov 29 04:44 PM
Vetter Thomas AlexCEONov 13 '23Sale19.0021,266404,054621,883Nov 15 04:43 PM
Vetter Thomas AlexCEONov 14 '23Sale19.3317,666341,484604,217Nov 15 04:43 PM
Vetter Thomas AlexCEONov 08 '23Sale19.0014,066267,254643,149Nov 13 05:01 PM
Marks Angelique StrongChief Legal OfficerNov 09 '23Sale18.525,594103,60187,105Nov 13 04:52 PM
Marks Angelique StrongChief Legal OfficerNov 08 '23Sale18.794,26380,10292,699Nov 13 04:52 PM
open in screener | open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR
Open in Screener

ATNF

180 Life Sciences Corp

Last Close
Oct 31 • 04:00PM ET
3.92
Dollar change
-0.01
Percentage change
-0.25 		%
ATNF 180 Life Sciences Corp daily Stock Chart
Peers: AMGN REGN BIIB ABBV VRTX GILD BMRN INCY ALNY NBIX
 | Held by: VXF
Index- P/E- EPS (ttm)-28.49 Insider Own8.37% Shs Outstand0.53M Perf Week1.03%
Market Cap4.03M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float0.49M Perf Month178.01%
Income-12.55M PEG- EPS next Q- Inst Own1.32% Short Float16.05% Perf Quarter112.47%
Sales0.00M P/S- EPS this Y- Inst Trans-53.44% Short Ratio0.04 Perf Half Y96.00%
Book/sh-0.44 P/B- EPS next Y- ROA-142.80% Short Interest0.08M Perf Year-52.02%
Cash/sh1.12 P/C3.50 EPS next 5Y- ROE-398.58% 52W Range1.16 - 17.75 Perf YTD-3.36%
Dividend Est.- P/FCF- EPS past 5Y- ROI- 52W High-77.92% Beta-
Dividend TTM- Quick Ratio0.58 Sales past 5Y0.00% Gross Margin- 52W Low237.93% ATR (14)1.18
Dividend Ex-Date- Current Ratio0.58 EPS Y/Y TTM93.71% Oper. Margin0.00% RSI (14)56.16 Volatility19.10% 26.83%
Employees4 Debt/Eq- Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price1520.00
Option/ShortNo / Yes LT Debt/Eq- EPS Q/Q100.10% Payout- Rel Volume0.17 Prev Close3.93
Sales Surprise- EPS Surprise84.62% Sales Q/Q- Earnings- Avg Volume1.93M Price3.92
SMA2020.12% SMA5061.96% SMA20059.60% Trades Volume320,737 Change-0.25%
Date Action Analyst Rating Change Price Target Change
Sep-15-21Initiated Maxim Group Buy $11
Today 08:00AM
180 Life Sciences Corp. Retains Senior Technology Consultant and Commences Gaming Technology Platform Integration
(ACCESSWIRE)
Oct-29-24 08:00AM
180 Life Sciences Corp. Appoints Mr. Jay Goodman to Board of Directors
(ACCESSWIRE)
Oct-25-24 09:00AM
Elray Resources Announces Strategic Sale of Crypto iGaming Technology
(GlobeNewswire) +9.79%
Oct-17-24 10:52AM
180 Life Sciences' Brave Decision To Switch to the iGaming Industry
(GuruFocus.com) -33.08%
Oct-16-24 08:00AM
180 Life Sciences Corp. Interim CEO, Blair Jordan, Issues Letter to Stockholders; Provides Update on Newly Acquired Gaming Technology Platform
(ACCESSWIRE) +325.66%
08:30AM Loading…
Oct-09-24 08:30AM
180 Life Sciences Corp. Regains Compliance with Nasdaq's Minimum Stockholders' Equity Rule and Expands into the Global iGaming Sector
(ACCESSWIRE) +16.10%
Oct-03-24 08:30AM
180 Life Sciences Corp. - Corporate Updates
(ACCESSWIRE)
Sep-12-24 04:15PM
180 Life Sciences Announces the Appointment of Omar Jimenez as Chief Financial Officer
(GlobeNewswire) +13.64% -9.50%
Jul-30-24 08:00AM
180 Life Sciences Announces Positive Topline Results of a Clinical Pharmacology Study Testing a New Solid Formulation of CBD with Enhanced Oral Uptake
(GlobeNewswire)
Jul-23-24 08:00AM
180 Life Sciences Granted an Additional Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements
(GlobeNewswire)
Jul-02-24 08:30AM
180 Life Sciences Granted Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements
(GlobeNewswire) +10.00%
May-16-24 11:53AM
ATNF Stock Earnings: 180 Life Sciences Reported Results for Q1 2024
(InvestorPlace) -14.95%
Mar-14-24 08:30AM
180 Life Sciences Regains Full Compliance with Nasdaq Minimum Bid Price Requirement
(GlobeNewswire)
Feb-26-24 07:00AM
180 Life Sciences Corp. Announces 1-For 19 Reverse Stock Split as Part of Nasdaq Compliance Plan
(GlobeNewswire) +5.49%
Dec-04-23 09:00AM
180 Life Sciences Engages Financial Advisor to Explore Strategic Alternatives
(GlobeNewswire)
09:00AM Loading…
Nov-28-23 09:00AM
180 Life Sciences Announces Review of Strategic Alternatives
(GlobeNewswire) +7.70%
Aug-14-23 04:29PM
180 Life Sciences Corp. Announces Closing of $3 Million Public Offering
(GlobeNewswire)
Aug-10-23 08:46AM
180 Life Sciences Corp. Announces Pricing of $3 Million Public Offering
(GlobeNewswire) -16.73%
Aug-07-23 09:00AM
180 Life Sciences Announces an Agreement for a Clinical Pharmacology Study Testing a New Formulation of CBD for Enhanced Oral Uptake
(GlobeNewswire)
Aug-03-23 08:00AM
180 Life Sciences Provides Update on Regulatory Approval Process in the UK and US for Dupuytrens Disease Treatment; Continues Consultations with the UK MHRA and Initiates a Type C Meeting Request With the US FDA
(GlobeNewswire)
Jul-31-23 08:00AM
180 Life Sciences Corp. Announces the Filing of a Provisional Patent Describing the Combination of CBD With GLP-1 Agonists to Suppress Appetite
(GlobeNewswire)
Apr-10-23 04:30PM
180 Life Sciences Corp. Announces Closing of $3 Million Registered Direct Offering and Concurrent Private Placement
(GlobeNewswire)
Apr-05-23 01:00PM
180 Life Sciences Corp. Announces $3 Million Registered Direct Offering and Concurrent Private Placement
(GlobeNewswire) -19.66%
Feb-27-23 08:30AM
180 Life Sciences Announces Presentation at the Gordon Conference
(GlobeNewswire) +5.51%
Feb-23-23 07:30AM
180 Life Sciences Announces Allowance of Claims for a US Patent for Dupuytrens Disease Treatment and Application
(GlobeNewswire) -10.82%
Feb-22-23 04:30PM
180 Life Sciences Provides Update Regarding Anti-TNF Frozen Shoulder Trial
(GlobeNewswire)
Jan-25-23 08:45AM
180 Life Sciences Announces Publication of a Review on the Treatments for Early Stage Dupuytrens Disease
(GlobeNewswire) +33.75%
Jan-17-23 08:00AM
180 Life Sciences Engages Kinexum for Assistance in Applying for Marketing Authorisation in the United Kingdom
(GlobeNewswire)
Jan-05-23 08:30AM
180 Life Sciences Regains Full Compliance with Nasdaq Minimum Bid Price Requirement
(GlobeNewswire) +12.33%
Jan-04-23 08:30AM
180 Life Sciences Announces Publication of a Review on the Biological Basis of Dupuytrens Disease
(GlobeNewswire) -17.36%
08:30AM Loading…
Dec-29-22 08:30AM
180 Life Sciences Corp. CEO James Woody, MD, PhD Issues Letter to Shareholders
(GlobeNewswire) +13.86%
Dec-23-22 08:00AM
180 Life Sciences Corp. Announces Closing of $6 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
(GlobeNewswire) -21.52%
Dec-20-22 02:11PM
180 Life Sciences Corp. Announces $6 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
(GlobeNewswire) -15.85%
Dec-16-22 09:00AM
180 Life Sciences Corp. Announces 1-for 20 Reverse Stock Split as Part of Nasdaq Compliance Plan
(GlobeNewswire) -11.67%
Nov-30-22 05:00PM
180 Life Sciences Provides Update on Progress To Seek Medicines and Healthcare Products Regulatory Agency Marketing Authorization for Anti-TNF Treatment of Early Stage Dupuytrens Contracture
(GlobeNewswire)
Nov-21-22 08:30AM
180 Life Sciences to Participate in A.G.P.s Virtual Biotech Conference to be Held November 30 December 1, 2022
(GlobeNewswire) -12.87%
Nov-15-22 12:37PM
CORRECTION: Adalimumab Found To Be A Likely Cost-Effective Treatment for Early-Stage Dupuytrens Disease
(GlobeNewswire) +12.02%
08:00AM
Adalimumab Found To Be A Likely Cost-Effective Treatment for Early-Stage Dupuytrens Disease
(GlobeNewswire)
Sep-26-22 08:30AM
180 Life Sciences Issues Letter to Stockholders
(GlobeNewswire)
Aug-22-22 08:30AM
180 Life Sciences with the University of Oxford Announce the Enrollment of the First Patient in a Trial of Anti-TNF for People with Early-Stage Frozen Shoulder
(GlobeNewswire) -10.53%
Jul-27-22 08:30AM
180 Life Sciences Announces That the University of Oxford Has Been Awarded a Grant From the National Institute for Health and Care Research in the U.K. to Conduct a Clinical Trial in Post Operative Delirium/Cognitive Deficit in a Jointly Funded Program With 180 Life Sciences Corp.
(GlobeNewswire)
Jul-21-22 08:00AM
180 Life Sciences Corp. Announces Closing of $6.5 Million Registered Direct Offering
(GlobeNewswire) +5.65%
Jul-18-22 08:30AM
180 Life Sciences Corp. Announces $6.5 Million Registered Direct Offering
(GlobeNewswire)
Jun-22-22 04:05PM
180 Life Sciences Corp. Issues Letter to Stockholders
(GlobeNewswire)
Jun-14-22 04:15PM
180 Life Sciences Provides Update on Correspondence Received from U.K. and U.S. Regulatory Authorities on Pathway for a Therapy That Could Prevent Progression of Early-Stage Dupuytrens Disease
(GlobeNewswire) -34.00%
May-31-22 08:30AM
180 Life Sciences Begins Consultations with UK and US Regulatory Authorities on Pathway for a Therapy that Could Prevent Progression of Early-Stage Dupuytrens Disease
(GlobeNewswire) +18.25%
May-02-22 08:00AM
REPEAT - 180 Life Sciences and University of Oxford Announce Publication of Positive Phase 2b Dupuytrens Disease Study Results in The Lancet Rheumatology
(GlobeNewswire) -20.75%
Apr-29-22 06:32PM
180 Life Sciences and University of Oxford Announce Publication of Positive Phase 2b Dupuytrens Disease Study Results in The Lancet Rheumatology
(GlobeNewswire) +22.54%
Feb-17-22 08:30AM
180 Life Sciences Corp. Forms Scientific Advisory Board
(GlobeNewswire) -6.61%
Jan-31-22 08:00AM
180 Life Sciences Corp. CEO James Woody, MD, PhD Issues Letter to Shareholders
(GlobeNewswire) +7.12%
Dec-28-21 11:00AM
180 Life Sciences Corp. To Participate in the Biotech Showcase 2022 Virtual Conference To be Held January 10-12, 2022
(GlobeNewswire) -5.75%
Dec-15-21 08:15AM
180 Life Sciences Corp. Enters into a License Agreement with University of Oxford for Regenerative Molecule HMGB1 for Liver Diseases
(GlobeNewswire)
Dec-12-21 06:06AM
Insider Buying: The 180 Life Sciences Corp. (NASDAQ:ATNF) Lead Independent Director Just Bought 328% More Shares
(Simply Wall St.)
Dec-10-21 05:15PM
180 Life Sciences Corp (ATNF) CEO James N. Woody Bought $53,375 of Shares
(GuruFocus.com)
Dec-06-21 08:15AM
180 Life Sciences Provides Follow-Up Information on Oxford University and the Companys Successful Dupuytrens Phase 2b Clinical Trial Results
(GlobeNewswire) +7.95%
Dec-01-21 02:45PM
180 Life Sciences Corp. Co-Founder Prof. Jagdeep Nanchahal Presents Keynote Address at the 2021 International Dupuytren Symposium, Including Top Line Data From the Phase 2b Clinical Trial
(GlobeNewswire) -20.85%
02:26PM
180 Life Sciences: Positive Data From Dupuytrens Disease Study Could Be a Big Catalyst, Says Analyst
(TipRanks)
Nov-22-21 08:30AM
180 Life Sciences Corp. Expands Patent Portfolio
(GlobeNewswire)
Nov-18-21 08:15AM
180 Life Sciences Corp. Co-Founder Prof. Jagdeep Nanchahal to Present a Keynote Address at the 2021 International Dupuytren Symposium
(GlobeNewswire) +9.86%
Nov-03-21 12:06PM
180 Life Sciences Corp. Names Quan A. Vu Chief Operating Officer/Chief Business Officer
(GlobeNewswire)
Oct-26-21 08:30AM
180 Life Sciences Corp. Publishes Pre-Clinical Study Report on the Effects of CBG Derivatives on Pain, Inflammation and Obesity in The Journal Molecules
(GlobeNewswire)
Sep-30-21 08:30AM
180 Life Sciences Corp. Continues To Expand Intellectual Property Portfolio
(GlobeNewswire) +5.66%
Sep-20-21 08:00AM
Celltrion Healthcare and 180 Life Sciences Enter Into Memorandum of Understanding for a Supply Agreement for the Ongoing Supply of Drug for Anti-TNF Product Trials for Novel Indications
(GlobeNewswire) -6.29%
Aug-30-21 08:30AM
180 Life Sciences Corp. CEO James Woody, MD, PhD Issues Letter to Stockholders
(GlobeNewswire)
Aug-24-21 08:30AM
180 Life Sciences Corp. Announces Closing of $15.0 Million Private Placement
(GlobeNewswire)
Aug-19-21 09:00AM
180 Life Sciences Corp. Announces $15.0 Million Private Placement
(GlobeNewswire) -25.73%
08:10AM
Is 180 Life Sciences Corp.'s (NASDAQ:ATNF) Shareholder Ownership Skewed Towards Insiders?
(Simply Wall St.)
Aug-02-21 08:00AM
Chairman of the 180 Life Sciences Clinical Advisory Board, Professor Jagdeep Nanchahal, has Been Invited To Present a Keynote Talk at the British Society for Surgery of the Hand (BSSH) at the Autumn Scientific Meeting in Oxford UK on September 9, 2021
(GlobeNewswire)
Jul-29-21 08:00AM
180 Life Sciences to Participate in Fireside Chat at BTIG Virtual Biotechnology Conference
(GlobeNewswire)
Jul-28-21 08:15AM
180 Life Sciences Announces Selection of Lead Synthetic CBD Analogue
(GlobeNewswire)
Jul-20-21 08:00AM
180 Life Sciences Regains Nasdaq Compliance Under Listing Rule 5250(c)(1)
(GlobeNewswire)
Jul-12-21 09:51AM
180 Life Sciences Regains Nasdaq Compliance for Listing Rules 5605(b)(1) and 5605(c)(2)
(GlobeNewswire) +9.75%
Jul-07-21 08:00AM
180 Life Sciences Expands Scientific Fibrosis Platform with Collagen VI as a Driver and Disease Biomarker in Human Fibrosis Published in the FEBS Journal
(GlobeNewswire)
Jun-28-21 08:15AM
180 Life Sciences Joins Russell Microcap® Index
(GlobeNewswire)
08:00AM
180 Life Sciences Files Plan with Nasdaq Related to Delayed Quarterly Report on Form 10-Q and Form 10-K
(GlobeNewswire)
Jun-10-21 09:12AM
180 Life Sciences Corp. Announces the Appointment of Pamela Marrone, PhD and Frank Knuettel II, MBA to Board of Directors
(GlobeNewswire)
Jun-01-21 08:00AM
180 Life Sciences Corp. to Present at LD Micro Invitational XI
(GlobeNewswire) +8.90%
May-28-21 08:00AM
180 Life Sciences Corp. Announces the Appointment of Russell T. Ray, MBA and Teresa DeLuca MD, MBA to Board of Directors
(GlobeNewswire) +7.96%
May-21-21 04:45PM
180 Life Sciences Corp. Receives Expected Notification From Nasdaq Related To Delayed Quarterly Report on Form 10-Q
(GlobeNewswire) +10.61%
Apr-20-21 08:00AM
180 Life Sciences Corp. Announces Collection of All Patient Data for Phase 2b Dupuytrens Disease Trial
(GlobeNewswire)
Apr-19-21 05:00PM
180 Life Sciences Corp. Receives Expected Notification From Nasdaq Related To Delayed Annual Report on Form 10-K
(GlobeNewswire) -16.53%
Apr-14-21 08:15AM
180 Life Sciences Corp. Congratulates Dr. Lynn Williams on International Dupuytren Award 2021
(GlobeNewswire)
Mar-26-21 08:30AM
180 Life Sciences Corp. (NASDAQ: ATNF) Recognized R&D Pioneers in Anti-Inflammatory Therapeutics
(GlobeNewswire) +18.57%
Mar-25-21 08:30AM
180 Life Sciences Corp. (NASDAQ: ATNF) in Hot Pursuit of New Anti-Inflammatory Blockbusters
(GlobeNewswire) +13.65%
Mar-24-21 08:30AM
180 Life Sciences Corp. CEO James Woody, MD, PhD Issues Letter to Stockholders
(GlobeNewswire)
Mar-08-21 01:30PM
180 Life Sciences Corp. to Present at Inaugural Emerging Growth Virtual Conference, presented by M Vest LLC and Maxim Group LLC
(GlobeNewswire) +5.46%
Feb-24-21 04:00PM
180 Life Sciences Corp. Announces Closing of $11.7 Million Private Placement
(GlobeNewswire) +11.06% -10.37%
Feb-19-21 09:00AM
180 Life Sciences Corp. Announces $11.7 Million Private Placement
(GlobeNewswire) -13.46%
Feb-17-21 12:00AM
Do Insiders Own Lots Of Shares In 180 Life Sciences Corp. (NASDAQ:ATNF)?
(Simply Wall St.) -5.45%
Jan-11-21 08:00AM
180 Life Sciences Corp. to Present at the Biotech Showcase(TM) Digital 2021 Conference
(Newsfile) +5.06%
Jan-05-21 02:50PM
180 Life Sciences Corp. to Present at the H.C. Wainwright Bioconnect 2021 Conference
(GlobeNewswire) +7.17%
Dec-03-20 11:08AM
180 Life Sciences Corp. to Present at the 13th Annual LD Micro Main Event Conference on Tuesday, December 15th at 1:40 PM EST
(GlobeNewswire)
Nov-24-20 10:00AM
180 Life Sciences Corp. to Ring Nasdaq Opening Bell on November 27, 2020
(GlobeNewswire) -6.93%
Nov-23-20 08:30AM
180 Life Sciences Corp. Continues to Expand Intellectual Property Portfolio With Additional Patent Grants
(GlobeNewswire) +17.44%
Nov-17-20 08:00AM
180 Life Sciences Corp. CEO James Woody, MD, PhD Issues Letter to Stockholders
(GlobeNewswire)
Nov-10-20 11:46AM
180 Life Sciences Announces Completion of Transaction with KBLM Merger Corp IV
(GlobeNewswire) -6.47%
180 Life Sciences Corp. operates as a clinical-stage biotechnology company, which engages in the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. The company was founded by Marc Feldmann, Lawrence J. Steinman, and Jonathan B. Rothbard on September 7, 2016 and is headquartered in Palo Alto, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Feldmann MarcDirectorDec 15 '23Sale0.1925,0004,700115,497Dec 18 04:15 PM
Woody James N.Chief Executive OfficerDec 15 '23Buy0.1925,0004,70066,888Dec 18 04:15 PM
open in screener | open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR
affiliate • advertise • toggle light mode • contact • help • privacy • do not sell my data
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.